In clinical settings, chromium deficiency has been linked to impaired glucose tolerance and emerging insulin resistance, particularly in patients on long‑term total parenteral nutrition where trace‑element provision is inadequate. Chromium functions as a cofactor that helps insulin signal more effectively at its receptor, so low chromium status can worsen post‑meal glucose excursions and increase insulin requirements despite otherwise unchanged diet or medications. Case reports and small series describe patients with unexplained hyperglycemia and neuropathic symptoms whose glucose tolerance, insulin sensitivity, and sometimes weight trajectory improved after chromium was added back to their nutrition support, underscoring that unrecognized deficiency can masquerade as primary type 2 diabetes or “idiopathic” insulin resistance. This medication is commonly used for Depression.
Brown RO, Forloines-Lynn S, Cross RE, Heizer WD. Chromium deficiency after long-term total parenteral nutrition. Dig Dis Sci. 1986 Jun;31(6):661-4. Anderson RA, Cheng N, Bryden NA, Polansky MM, Cheng N, Chi J, Feng J. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes. 1997 Nov;46(11):1786-91. Anderson RA, Polansky MM, Bryden NA, Roginski EE, Mertz W, Glinsmann W. Chromium supplementation of human subjects: effects on glucose, insulin, and lipid variables. Metabolism. 1983 Sep;32(9):894-9. Riales R, Albrink MJ. Effect of chromium chloride supplementation on glucose tolerance and serum lipids including high-density lipoprotein of adult men. Am J Clin Nutr. 1981 Dec;34(12):2670-8. Anderson RA. Chromium and insulin resistance. Nutrition Research Reviews. 2003;16(2):267-275.
Some side effects may be linked to nutrient depletion caused by this medication.
Research suggests that folic acid supplementation can significantly improve the effectiveness of SSRI medications such as fluoxetine (commonly known as Prozac). This benefit seems to be linked to lowering blood levels of homocysteine, an amino acid. Elevated homocysteine levels have been associated with depression. Supplementing with sufficient folic acid may help the body regulate homocysteine levels, potentially creating a more favorable environment for antidepressants to work effectively.
Research suggests the trace mineral chromium may offer some benefits for people experiencing depression, particularly those with atypical depression. Atypical depression is characterized by symptoms like increased appetite, carbohydrate cravings, and weight gain, alongside feelings of sadness and low mood. Studies show chromium supplementation might improve these specific symptoms in people with atypical depression who also have strong carbohydrate cravings. The potential explanation lies in chromium's possible effects on insulin utilization and brain chemicals like serotonin and norepinephrine, both of which are involved in mood regulation. Supplementation with chromium is suggested to support mood and help protect against depression.